Montara Therapeutics
Brain-targeted therapies
Montara Therapeutics is advancing precision medicine for central nervous system disorders with its BrainOnly™ platform. This innovative approach addresses neurodegenerative and neurological diseases by combining a brain-penetrant, target-specific drug with a non-brain-penetrant peripheral blocker. This strategy prevents peripheral toxicities while enhancing drug efficacy in the brain. The platform is based on research from UCSF and is licensed from them. Montara’s technology aims to tackle previously undruggable targets and improve safety and effectiveness in treating conditions like Alzheimer’s, Parkinson’s, and brain cancers.
Visit website: https://montaratx.com/
Details last updated 07-Aug-2024
Montara Therapeutics News
Montara Therapeutics raises $8M to develop brain-targeted drugs
Longevity Technology - 01-Aug-2024
Approach is based on research from UCSF and could transform how diseases are treated
Read more...